Observational Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jan 27, 2020; 12(1): 21-33
Published online Jan 27, 2020. doi: 10.4254/wjh.v12.i1.21
Table 1 Clinical characteristics according to objective response - target lesion response
VariableNR (n = 44)RE (n = 141)Total (n = 185)P value
Gender (male), n (%)39 (88.6)118 (83.7)157 (84.9)0.424
Age (yr), mean ± SD58.7 ± 9.257.4 ± 8.157.7 ± 8.40.3631
BMI, mean ± SD27.2 ± 4.227 ± 4.827.1 ± 4.70.7171
Systemic hypertension, n (%)19 (43.2)60 (42.6)79 (42.7)0.941
DM, n (%)17 (38.6)46 (32.6)63 (34.1)0.463
DLP, n (%)1 (2.3)9 (6.4)10 (5.4)0.4562
Smoker (%)12 (27.3)28 (19.9)40 (21.6)0.297
Coagulopathy3, 4, n (%)21 (47.7)63 (44.7)84 (45.4)0.723
Thrombocitopenia5, n (%)28 (63.6)93 (66)121 (65.4)0.778
CHILD, n (%)0.7056
A19 (45.2)72 (52.6)91 (50.8)
B20 (47.6)56 (40.9)76 (42.5)
C3 (7.1)9 (6.6)12 (6.7)
MELD, mean ± SD12.1 ± 3.511.9 ± 3.512 ± 3.50.6051
Downstaging7 - Milan Criteria, n (%)9 (20.5)45 (31.9)54 (29.2)0.144
Multinodular HCC, n (%)19 (43.2)68 (48.2)87 (47)0.558